Why Animal Oral Mucosa Does Not Perfectly Reproduce Human Buccal or Sublingual Tissue

Animal oral mucosa does not perfectly reproduce human buccal or sublingual tissue because species differ in epithelial thickness, keratinization, lipid organization, enzyme activity, anatomical structure, and oral physiology. Animal tissue remains valuable for peptide-delivery research, but transport results should be treated as model-specific evidence rather than direct numerical predictions of human mucosal absorption.

Animal models play an important role in buccal and sublingual peptide delivery research because suitable human oral tissue can be difficult to obtain in standardized quantities. Porcine tissue in particular is widely used because its non-keratinized oral epithelium has useful similarities to human tissue. Those similarities make it a practical model, not an identical substitute.

Research-use notice: InStrips materials are intended exclusively for research and analytical applications. This article examines why animal oral mucosa cannot perfectly reproduce human buccal or sublingual peptide transport, including species differences in tissue structure, enzymatic activity, permeability, and oral physiology.

Animal Models Are Used Because Human Tissue Has Practical Limitations

Fresh human buccal or sublingual tissue is not always available in:

• large quantities
• standardized anatomical regions
• consistent thickness
• predictable condition

Animal tissue provides a more accessible system for repeated formulation experiments.

The Goal Is Usually Approximation, Not Anatomical Identity

A useful animal model may reproduce selected human characteristics closely enough to:

• rank formulations
• compare enhancers
• study peptide stability
• investigate barrier mechanisms

It does not need to be identical in every physiological feature.

Porcine Mucosa Is One of the Most Common Oral Models

Pig oral tissue is widely used because several features resemble human non-keratinized oral mucosa.

This has made porcine buccal tissue particularly useful in:

• Franz-cell experiments
• flow-through permeation studies
• mucoadhesion research
• peptide-film screening

Recent Peptide Research Still Uses Porcine Oromucosa as a Translational Step

A recent standardized ex vivo porcine oromucosal model was developed specifically for evaluating peptide flux from film formulations.

The researchers described the model as a screening step that can support subsequent pharmacokinetic evaluation in pigs and humans.

That sequence illustrates the correct translational role of animal mucosa.

Porcine and Human Tissue Can Differ in Absolute Permeability

Comparative research has demonstrated that different mucosal models can produce different permeability values for the same compounds.

Porcine buccal mucosa has sometimes shown lower permeability than alternative mucosal models used to approximate human buccal transport.

This means an ex vivo pig value should not be converted directly into a human absorption percentage.

Species Differences Can Affect Different Molecules Differently

The size of the animal-to-human difference may depend on whether a molecule is:

• small
• large
• hydrophilic
• lipophilic
• charged

Peptides are particularly challenging because they are often relatively large and hydrophilic.

Peptide Transport Is Usually Low Without Formulation Assistance

Buccal peptide absorption can be limited by:

• molecular size
• hydrophilicity
• epithelial resistance
• enzymatic degradation

This means small structural differences between animal and human tissue can become important when baseline permeability is already low.

Epithelial Thickness Can Differ Between Species

Diffusion generally becomes slower as the transport path becomes longer.

Differences in epithelial thickness can therefore influence:

• flux
• lag time
• total permeated amount

Keratinization Can Create a Different Barrier

Animal oral regions can differ from humans in the extent and distribution of keratinized tissue.

A tissue that appears anatomically convenient may therefore provide a barrier unlike the intended human buccal or sublingual site.

Animal Species Should Be Selected With the Human Target Site in Mind

A model for non-keratinized human buccal tissue should ideally reproduce:

• epithelial organization
• barrier characteristics
• relevant tissue thickness

Convenience alone is not sufficient.

Buccal and Sublingual Sites Need Different Models

A porcine cheek sample should not automatically serve as a model for human sublingual mucosa.

The floor of the mouth can differ in:

• epithelial thickness
• permeability
• vascular environment

Animal Mouth-Floor Tissue May Be More Permeable Than Buccal Tissue

Experimental comparisons have shown greater permeability through porcine mouth-floor mucosa than through porcine buccal mucosa for several marker compounds.

This supports the broader principle that anatomical site must accompany species identification.

Lipid Composition Can Influence the Barrier

Non-keratinized oral epithelial cells contain intercellular lipids that contribute to permeability.

Species differences in these lipids can alter transport, particularly for molecules interacting strongly with membrane components.

Enzymatic Activity Is Especially Important for Peptides

A small-molecule drug may remain chemically intact while crossing tissue.

A peptide can be cleaved by:

• aminopeptidases
• carboxypeptidases
• other proteolytic enzymes

This means animal tissue models need to reproduce not only physical permeability but also relevant metabolic activity.

Porcine and Human Enzyme Profiles Are Not Identical

Comparative work with human and porcine buccal epithelium has found differences in selected enzyme activities.

A peptide that appears stable in one tissue source may therefore degrade more rapidly in another.

Peptide Degradation Can Alter Apparent Permeability

If only intact peptide is measured in the receiver compartment, extensive degradation can make the tissue appear poorly permeable.

If an assay also detects fragments, transport could appear higher.

Analytical specificity therefore becomes part of animal-to-human translation.

Blood Flow Is Missing From Ex Vivo Animal Tissue

Excised tissue cannot reproduce vascular removal of peptide from the absorption site.

In living human mucosa, local circulation helps maintain a concentration gradient by carrying absorbed peptide away.

Laboratory receiver fluid approximates this process but cannot reproduce it perfectly.

Saliva Is Also Difficult to Model Accurately

Living oral environments include continuous changes in:

• salivary volume
• pH
• protein content
• enzyme concentration

An excised animal tissue mounted in buffer lacks these dynamic conditions.

Animal In Vivo Models Restore Some of This Complexity

Living animals provide:

• salivary secretion
• blood circulation
• metabolism
• whole-body pharmacokinetics

However, they introduce another set of species differences.

Animal Behavior Can Affect Film Residence

A dosage form placed in an animal mouth may encounter species-specific:

• tongue movement
• chewing
• saliva production
• swallowing behavior

These can make film retention different from human use.

Oral Cavity Dimensions Affect Dosage-Form Fit

A film sized appropriately for one animal species may cover a different proportion of the mucosal surface than it would in a person.

This can alter:

• contact area
• local concentration
• salivary exposure

Permeation Enhancers May Translate Differently Between Species

An enhancer can alter epithelial barrier function.

If membrane composition differs between animal and human tissue, the magnitude of enhancement may also differ.

A strong enhancer effect in animal mucosa therefore needs human confirmation.

Tolerability Can Differ Too

An enhancer that causes little visible damage in one species may affect human mucosa differently.

Barrier recovery and repeated-exposure effects need model-specific evaluation.

Animal Tissue Still Has High Value for Comparative Screening

The limitations do not make animal mucosa unsuitable.

A standardized tissue model can be highly useful for ranking:

• Film A versus Film B
• one polymer versus another
• one enhancer concentration versus another

Relative Ranking May Translate Better Than Absolute Numbers

If a model consistently identifies the better-performing formulation, it can guide development even when its exact permeability coefficient differs from human tissue.

This is an important distinction between:

• predicting rank order
• predicting exact human bioavailability

Standardization Makes Animal Models More Useful

A reliable model should control variables such as:

• animal age where possible
• anatomical region
• tissue thickness
• storage
• preparation method
• integrity

Reducing experimental variability makes true formulation differences easier to detect.

Animal Data Should Be Bridged to Human Data

The strongest validation occurs when researchers compare animal-model predictions with human pharmacokinetic results.

They can then ask:

• Did the model rank formulations correctly?
• Did it overestimate permeability?
• Did it underestimate variability?

A Validated Model Becomes More Predictive Over Time

Repeated comparison against human results can reveal which experimental conditions produce the best translation.

This is more useful than assuming one animal species is universally equivalent to humans.

Human Tissue Does Not Eliminate Every Translation Problem

Even excised human mucosa lacks:

• normal perfusion
• continuous saliva
• movement
• whole-body pharmacokinetics

The ultimate translational reference for systemic delivery remains an appropriately designed human exposure study.

Animal Models Should Be Described Precisely

Instead of saying simply that a peptide crosses oral mucosa, a stronger description would specify that:

The peptide crossed a particular animal mucosal preparation under defined ex vivo conditions.

This keeps the evidence attached to the experiment that generated it.

Tissue Source Explains Part of the Cross-Model Variation

The broader role of anatomical location, tissue preparation, and species is discussed in why oral mucosal tissue source can change peptide transport results.

Final Perspective

Animal oral mucosa remains one of the most useful tools available for buccal and sublingual peptide-delivery development. Porcine tissue in particular can provide a reproducible, structurally relevant platform for screening peptide formulations before more complex studies are undertaken.

Its value comes from approximation rather than perfect equivalence. Species differences in epithelial architecture, tissue thickness, enzymatic activity, permeability, saliva, and oral physiology mean that animal results cannot provide exact human bioavailability predictions on their own.

The strongest translational approach therefore uses animal mucosa to compare and refine formulations, validates promising findings in increasingly physiological models, and ultimately relies on human studies when the research question concerns human systemic exposure.